Celgene

American biopharmaceutical company

Celgene Corporation is a pharmaceutical company incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Vidaza is approved for the treatment of patients with MDS.

Celgene News and Videos   LIVE

ℹī¸ This is a LIVE page which updates automatically as we're monitoring our hand-curated selection of verified and trustworthy media outlets

You might like